JAZZ - Jazz Pharmaceuticals plc

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
Enterprise Value 3
Trailing P/E
Forward P/E 1
PEG Ratio (5 yr expected) 1
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue 3
Enterprise Value/EBITDA 6

Trading Information

Stock Price History

Beta (5Y Monthly) 1.14
52-Week Change 317.40%
S&P500 52-Week Change 326.46%
52 Week High 3154.24
52 Week Low 3116.52
50-Day Moving Average 3149.17
200-Day Moving Average 3136.00

Share Statistics

Avg Vol (3 month) 3513.7k
Avg Vol (10 day) 3616.42k
Shares Outstanding 556.57M
Float 51.98M
% Held by Insiders 12.65%
% Held by Institutions 194.79%
Shares Short (Dec 30, 2019) 43.39M
Short Ratio (Dec 30, 2019) 47.13
Short % of Float (Dec 30, 2019) 46.15%
Short % of Shares Outstanding (Dec 30, 2019) 45.99%
Shares Short (prior month Nov 28, 2019) 43.08M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2018
Most Recent Quarter (mrq)Sep 29, 2019


Profit Margin 29.61%
Operating Margin (ttm)40.09%

Management Effectiveness

Return on Assets (ttm)9.36%
Return on Equity (ttm)20.02%

Income Statement

Revenue (ttm)2.06B
Revenue Per Share (ttm)35.78
Quarterly Revenue Growth (yoy)14.60%
Gross Profit (ttm)1.77B
Net Income Avi to Common (ttm)608.84M
Diluted EPS (ttm)10.44
Quarterly Earnings Growth (yoy)-31.50%

Balance Sheet

Total Cash (mrq)1.07B
Total Cash Per Share (mrq)18.92
Total Debt (mrq)1.77B
Total Debt/Equity (mrq)57.99
Current Ratio (mrq)3.89
Book Value Per Share (mrq)53.95

Cash Flow Statement

Operating Cash Flow (ttm)906.7M
Levered Free Cash Flow (ttm)674.13M